HCP5 - Revision history

Citation bot: Add: pages, issue, volume, date. | Use this bot. Report bugs. | Suggested by Whoop whoop pull up | #UCB_webform 2490/3364

2024-04-06T16:16:59Z

Add: pages, issue, volume, date. | Use this bot. Report bugs. | Suggested by Whoop whoop pull up | #UCB_webform 2490/3364

← Previous revision		Revision as of 16:16, 6 April 2024
Line 3:		Line 3:
	One variation of HCP5 appears to provide some delay or resistance to the development of [[AIDS]] when a person is infected with [[HIV]]. This variation of HCP5 frequently occurs in conjunction with a particular version of an [[immune system]] gene called [[HLA-B]].<ref name=SN/>		One variation of HCP5 appears to provide some delay or resistance to the development of [[AIDS]] when a person is infected with [[HIV]]. This variation of HCP5 frequently occurs in conjunction with a particular version of an [[immune system]] gene called [[HLA-B]].<ref name=SN/>

	HCP5 has been reported to become [[upregulated]] after [[human papillomavirus infection]] and may promote the development of [[cervical cancer]].<ref>{{cite journal \| vauthors = Ramachandran D, Schürmann P, Mao Q, Wang Y, Bretschneider LM, Speith LM, Hülse F, Enßen J, Bousset K, Jentschke M, Böhmer G, Strauß HG, Hirchenhain C, Schmidmayr M, Tarbiat J, Runnebaum I, Dürst M, Hein A, Koch M, Ruebner M, Ekici A, Beckmann MW, Fasching PA, Luyten A, Petry KU, Hillemanns P, Dörk T \| title = Association of genomic variants at the Human Leukocyte Antigen locus with cervical cancer risk, HPV status, and gene expression levels\| journal = Int J Cancer \| pmid = 32580243 \| doi = 10.1002/ijc.33171\| doi-access = free }}</ref><ref>{{cite journal \| vauthors = Yu Y, Shen HM, Fang DM, Meng QJ, Xin YH\| title = LncRNA HCP5 promotes the development of cervical cancer by regulating MACC1 via suppression of microRNA-15a\| journal = Eur Rev Med Pharmacol Sci \| pmid = 30070314 \| doi = 10.26355/eurrev_201808_15616}}</ref>		HCP5 has been reported to become [[upregulated]] after [[human papillomavirus infection]] and may promote the development of [[cervical cancer]].<ref>{{cite journal \| vauthors = Ramachandran D, Schürmann P, Mao Q, Wang Y, Bretschneider LM, Speith LM, Hülse F, Enßen J, Bousset K, Jentschke M, Böhmer G, Strauß HG, Hirchenhain C, Schmidmayr M, Tarbiat J, Runnebaum I, Dürst M, Hein A, Koch M, Ruebner M, Ekici A, Beckmann MW, Fasching PA, Luyten A, Petry KU, Hillemanns P, Dörk T \| title = Association of genomic variants at the Human Leukocyte Antigen locus with cervical cancer risk, HPV status, and gene expression levels\| journal = Int J Cancer \| date = 2020\| volume = 147\| issue = 9\| pages = 2458–2468\| pmid = 32580243 \| doi = 10.1002/ijc.33171\| doi-access = free }}</ref><ref>{{cite journal \| vauthors = Yu Y, Shen HM, Fang DM, Meng QJ, Xin YH\| title = LncRNA HCP5 promotes the development of cervical cancer by regulating MACC1 via suppression of microRNA-15a\| journal = Eur Rev Med Pharmacol Sci \| date = 2018\| volume = 22\| issue = 15\| pmid = 30070314 \| doi = 10.26355/eurrev_201808_15616}}</ref>

	==Notes and references==		==Notes and references==

OAbot: Open access bot: doi added to citation with #oabot.

2021-01-14T10:38:48Z

Open access bot: doi added to citation with #oabot.

← Previous revision		Revision as of 10:38, 14 January 2021
Line 3:		Line 3:
	One variation of HCP5 appears to provide some delay or resistance to the development of [[AIDS]] when a person is infected with [[HIV]]. This variation of HCP5 frequently occurs in conjunction with a particular version of an [[immune system]] gene called [[HLA-B]].<ref name=SN/>		One variation of HCP5 appears to provide some delay or resistance to the development of [[AIDS]] when a person is infected with [[HIV]]. This variation of HCP5 frequently occurs in conjunction with a particular version of an [[immune system]] gene called [[HLA-B]].<ref name=SN/>

	HCP5 has been reported to become [[upregulated]] after [[human papillomavirus infection]] and may promote the development of [[cervical cancer]].<ref>{{cite journal \| vauthors = Ramachandran D, Schürmann P, Mao Q, Wang Y, Bretschneider LM, Speith LM, Hülse F, Enßen J, Bousset K, Jentschke M, Böhmer G, Strauß HG, Hirchenhain C, Schmidmayr M, Tarbiat J, Runnebaum I, Dürst M, Hein A, Koch M, Ruebner M, Ekici A, Beckmann MW, Fasching PA, Luyten A, Petry KU, Hillemanns P, Dörk T \| title = Association of genomic variants at the Human Leukocyte Antigen locus with cervical cancer risk, HPV status, and gene expression levels\| journal = Int J Cancer \| pmid = 32580243 \| doi = 10.1002/ijc.33171}}</ref><ref>{{cite journal \| vauthors = Yu Y, Shen HM, Fang DM, Meng QJ, Xin YH\| title = LncRNA HCP5 promotes the development of cervical cancer by regulating MACC1 via suppression of microRNA-15a\| journal = Eur Rev Med Pharmacol Sci \| pmid = 30070314 \| doi = 10.26355/eurrev_201808_15616}}</ref>		HCP5 has been reported to become [[upregulated]] after [[human papillomavirus infection]] and may promote the development of [[cervical cancer]].<ref>{{cite journal \| vauthors = Ramachandran D, Schürmann P, Mao Q, Wang Y, Bretschneider LM, Speith LM, Hülse F, Enßen J, Bousset K, Jentschke M, Böhmer G, Strauß HG, Hirchenhain C, Schmidmayr M, Tarbiat J, Runnebaum I, Dürst M, Hein A, Koch M, Ruebner M, Ekici A, Beckmann MW, Fasching PA, Luyten A, Petry KU, Hillemanns P, Dörk T \| title = Association of genomic variants at the Human Leukocyte Antigen locus with cervical cancer risk, HPV status, and gene expression levels\| journal = Int J Cancer \| pmid = 32580243 \| doi = 10.1002/ijc.33171\| doi-access = free }}</ref><ref>{{cite journal \| vauthors = Yu Y, Shen HM, Fang DM, Meng QJ, Xin YH\| title = LncRNA HCP5 promotes the development of cervical cancer by regulating MACC1 via suppression of microRNA-15a\| journal = Eur Rev Med Pharmacol Sci \| pmid = 30070314 \| doi = 10.26355/eurrev_201808_15616}}</ref>

	==Notes and references==		==Notes and references==

Lembit Staan at 22:42, 9 July 2020

2020-07-09T22:42:02Z

← Previous revision		Revision as of 22:42, 9 July 2020
Line 1:		Line 1:
	The [[gene]] known as '''HCP5''' ('''[[Human leukocyte antigen\|HLA]] Complex P5''') is a human [[endogenous retrovirus]], meaning that it is a [[viral fossil\|fossil of an ancient virus]] that at one time infected people, but has now become an integral part of the [[human genome]].<ref name=SN>AIDS Abated, B. Vastag, Science News Vol.172 No.3, 21 July 2007</ref>		The [[gene]] known as '''HCP5''' ('''[[Human leukocyte antigen\|HLA]] Complex P5''') is a human [[endogenous retrovirus]], meaning that it is a [[viral fossil\|fossil of an ancient virus]] that at one time infected people, but has now become an integral part of the [[human genome]].<ref name=SN>AIDS Abated, B. Vastag, Science News Vol.172 No.3, 21 July 2007</ref>

	One variation of ~~'''~~HCP5~~'''~~ appears to provide some delay or resistance to the development of [[AIDS]] when a person is infected with [[HIV]]. This variation of ~~'''~~HCP5~~'''~~ frequently occurs in conjunction with a particular version of an [[immune system]] gene called [[HLA-B]].<ref name=SN/>		One variation of HCP5 appears to provide some delay or resistance to the development of [[AIDS]] when a person is infected with [[HIV]]. This variation of HCP5 frequently occurs in conjunction with a particular version of an [[immune system]] gene called [[HLA-B]].<ref name=SN/>

	~~'''~~HCP5~~'''~~ has been reported to become upregulated after [[human papillomavirus infection]] and may promote the development of [[cervical cancer]].<ref>{{cite journal \| vauthors = Ramachandran D, Schürmann P, Mao Q, Wang Y, Bretschneider LM, Speith LM, Hülse F, Enßen J, Bousset K, Jentschke M, Böhmer G, Strauß HG, Hirchenhain C, Schmidmayr M, Tarbiat J, Runnebaum I, Dürst M, Hein A, Koch M, Ruebner M, Ekici A, Beckmann MW, Fasching PA, Luyten A, Petry KU, Hillemanns P, Dörk T \| title = Association of genomic variants at the Human Leukocyte Antigen locus with cervical cancer risk, HPV status, and gene expression levels\| journal = Int J Cancer \| pmid = 32580243 \| doi = 10.1002/ijc.33171}}</ref><ref>{{cite journal \| vauthors = Yu Y, Shen HM, Fang DM, Meng QJ, Xin YH\| title = LncRNA HCP5 promotes the development of cervical cancer by regulating MACC1 via suppression of microRNA-15a\| journal = Eur Rev Med Pharmacol Sci \| pmid = 30070314 \| doi = 10.26355/eurrev_201808_15616}}</ref>		HCP5 has been reported to become [[upregulated]] after [[human papillomavirus infection]] and may promote the development of [[cervical cancer]].<ref>{{cite journal \| vauthors = Ramachandran D, Schürmann P, Mao Q, Wang Y, Bretschneider LM, Speith LM, Hülse F, Enßen J, Bousset K, Jentschke M, Böhmer G, Strauß HG, Hirchenhain C, Schmidmayr M, Tarbiat J, Runnebaum I, Dürst M, Hein A, Koch M, Ruebner M, Ekici A, Beckmann MW, Fasching PA, Luyten A, Petry KU, Hillemanns P, Dörk T \| title = Association of genomic variants at the Human Leukocyte Antigen locus with cervical cancer risk, HPV status, and gene expression levels\| journal = Int J Cancer \| pmid = 32580243 \| doi = 10.1002/ijc.33171}}</ref><ref>{{cite journal \| vauthors = Yu Y, Shen HM, Fang DM, Meng QJ, Xin YH\| title = LncRNA HCP5 promotes the development of cervical cancer by regulating MACC1 via suppression of microRNA-15a\| journal = Eur Rev Med Pharmacol Sci \| pmid = 30070314 \| doi = 10.26355/eurrev_201808_15616}}</ref>

	==Notes and references==		==Notes and references==

193.174.111.250: Added a sentence about relevance in cancer and two references

2020-07-09T21:50:41Z

Added a sentence about relevance in cancer and two references

← Previous revision		Revision as of 21:50, 9 July 2020
Line 3:		Line 3:
	One variation of '''HCP5''' appears to provide some delay or resistance to the development of [[AIDS]] when a person is infected with [[HIV]]. This variation of '''HCP5''' frequently occurs in conjunction with a particular version of an [[immune system]] gene called [[HLA-B]].<ref name=SN/>		One variation of '''HCP5''' appears to provide some delay or resistance to the development of [[AIDS]] when a person is infected with [[HIV]]. This variation of '''HCP5''' frequently occurs in conjunction with a particular version of an [[immune system]] gene called [[HLA-B]].<ref name=SN/>

	'''HCP5''' has been reported to become upregulated ~~when cervical cells become infected with~~ [[human papillomavirus]] and may promote the development of cervical ~~carcinoma~~.<ref>{{cite journal \| vauthors = Ramachandran D, Schürmann P, Mao Q, Wang Y, Bretschneider LM, Speith LM, Hülse F, Enßen J, Bousset K, Jentschke M, Böhmer G, Strauß HG, Hirchenhain C, Schmidmayr M, Tarbiat J, Runnebaum I, Dürst M, Hein A, Koch M, Ruebner M, Ekici A, Beckmann MW, Fasching PA, Luyten A, Petry KU, Hillemanns P, Dörk T \| title = Association of genomic variants at the Human Leukocyte Antigen locus with cervical cancer risk, HPV status, and gene expression levels\| journal = Int J Cancer \| pmid = 32580243 \| doi = 10.1002/ijc.33171}}</ref><ref>{{cite journal \| vauthors = Yu Y, Shen HM, Fang DM, Meng QJ, Xin YH\| title = LncRNA HCP5 promotes the development of cervical cancer by regulating MACC1 via suppression of microRNA-15a\| journal = Eur Rev Med Pharmacol Sci \| pmid = 30070314 \| doi = 10.26355/eurrev_201808_15616}}</ref>		'''HCP5''' has been reported to become upregulated after [[human papillomavirus infection]] and may promote the development of [[cervical cancer]].<ref>{{cite journal \| vauthors = Ramachandran D, Schürmann P, Mao Q, Wang Y, Bretschneider LM, Speith LM, Hülse F, Enßen J, Bousset K, Jentschke M, Böhmer G, Strauß HG, Hirchenhain C, Schmidmayr M, Tarbiat J, Runnebaum I, Dürst M, Hein A, Koch M, Ruebner M, Ekici A, Beckmann MW, Fasching PA, Luyten A, Petry KU, Hillemanns P, Dörk T \| title = Association of genomic variants at the Human Leukocyte Antigen locus with cervical cancer risk, HPV status, and gene expression levels\| journal = Int J Cancer \| pmid = 32580243 \| doi = 10.1002/ijc.33171}}</ref><ref>{{cite journal \| vauthors = Yu Y, Shen HM, Fang DM, Meng QJ, Xin YH\| title = LncRNA HCP5 promotes the development of cervical cancer by regulating MACC1 via suppression of microRNA-15a\| journal = Eur Rev Med Pharmacol Sci \| pmid = 30070314 \| doi = 10.26355/eurrev_201808_15616}}</ref>

	==Notes and references==		==Notes and references==

193.174.111.250 at 21:40, 9 July 2020

2020-07-09T21:40:13Z

← Previous revision		Revision as of 21:40, 9 July 2020
Line 2:		Line 2:

	One variation of '''HCP5''' appears to provide some delay or resistance to the development of [[AIDS]] when a person is infected with [[HIV]]. This variation of '''HCP5''' frequently occurs in conjunction with a particular version of an [[immune system]] gene called [[HLA-B]].<ref name=SN/>		One variation of '''HCP5''' appears to provide some delay or resistance to the development of [[AIDS]] when a person is infected with [[HIV]]. This variation of '''HCP5''' frequently occurs in conjunction with a particular version of an [[immune system]] gene called [[HLA-B]].<ref name=SN/>

			'''HCP5''' has been reported to become upregulated when cervical cells become infected with [[human papillomavirus]] and may promote the development of cervical carcinoma.<ref>{{cite journal \| vauthors = Ramachandran D, Schürmann P, Mao Q, Wang Y, Bretschneider LM, Speith LM, Hülse F, Enßen J, Bousset K, Jentschke M, Böhmer G, Strauß HG, Hirchenhain C, Schmidmayr M, Tarbiat J, Runnebaum I, Dürst M, Hein A, Koch M, Ruebner M, Ekici A, Beckmann MW, Fasching PA, Luyten A, Petry KU, Hillemanns P, Dörk T \| title = Association of genomic variants at the Human Leukocyte Antigen locus with cervical cancer risk, HPV status, and gene expression levels\| journal = Int J Cancer \| pmid = 32580243 \| doi = 10.1002/ijc.33171}}</ref><ref>{{cite journal \| vauthors = Yu Y, Shen HM, Fang DM, Meng QJ, Xin YH\| title = LncRNA HCP5 promotes the development of cervical cancer by regulating MACC1 via suppression of microRNA-15a\| journal = Eur Rev Med Pharmacol Sci \| pmid = 30070314 \| doi = 10.26355/eurrev_201808_15616}}</ref>

	==Notes and references==		==Notes and references==

Omnipaedista: edited formatting

2014-04-21T21:15:21Z

edited formatting

← Previous revision		Revision as of 21:15, 21 April 2014
Line 1:		Line 1:
	The [[gene]] known as '''HCP5''' ('''[[Human leukocyte antigen\|HLA]] Complex P5''') is a human [[endogenous retrovirus]], meaning that it is a [[viral fossil\|fossil of an ancient virus]] that at one time infected people, but has now become an integral part of the [[human genome]].<ref name=SN>AIDS Abated, B. Vastag, Science News Vol.172 No.3, 21 July 2007</ref>		The [[gene]] known as '''HCP5''' ('''[[Human leukocyte antigen\|HLA]] Complex P5''') is a human [[endogenous retrovirus]], meaning that it is a [[viral fossil\|fossil of an ancient virus]] that at one time infected people, but has now become an integral part of the [[human genome]].<ref name=SN>AIDS Abated, B. Vastag, Science News Vol.172 No.3, 21 July 2007</ref>


	One variation of '''HCP5''' appears to provide some delay or resistance to the development of [[AIDS]] when a person is infected with [[HIV]]. This variation of '''HCP5''' frequently occurs in conjunction with a particular version of an [[immune system]] gene called [[HLA-B]].<ref name=SN/>		One variation of '''HCP5''' appears to provide some delay or resistance to the development of [[AIDS]] when a person is infected with [[HIV]]. This variation of '''HCP5''' frequently occurs in conjunction with a particular version of an [[immune system]] gene called [[HLA-B]].<ref name=SN/>

	==Notes==		==Notes and references==
	{{Reflist}}		{{Reflist}}

JL-Bot: removing orphan template as not a valid orphan

2011-08-20T16:49:27Z

removing orphan template as not a valid orphan

← Previous revision		Revision as of 16:49, 20 August 2011
Line 1:		Line 1:
	{{Orphan\|date=February 2009}}
	The [[gene]] known as '''HCP5''' ('''[[Human leukocyte antigen\|HLA]] Complex P5''') is a human [[endogenous retrovirus]], meaning that it is a [[viral fossil\|fossil of an ancient virus]] that at one time infected people, but has now become an integral part of the [[human genome]].<ref name=SN>AIDS Abated, B. Vastag, Science News Vol.172 No.3, 21 July 2007</ref>		The [[gene]] known as '''HCP5''' ('''[[Human leukocyte antigen\|HLA]] Complex P5''') is a human [[endogenous retrovirus]], meaning that it is a [[viral fossil\|fossil of an ancient virus]] that at one time infected people, but has now become an integral part of the [[human genome]].<ref name=SN>AIDS Abated, B. Vastag, Science News Vol.172 No.3, 21 July 2007</ref>

Arcadian: cat

2011-08-05T18:01:40Z

cat

← Previous revision		Revision as of 18:01, 5 August 2011
Line 8:		Line 8:
	{{Reflist}}		{{Reflist}}

			{{Retroviruses}}
	[[Category:Genomics]]		[[Category:Genomics]]
	[[Category:Endogenous retroviruses]]		[[Category:Endogenous retroviruses]]

Arcadian: removed Category:Retroviruses; added Category:Endogenous retroviruses using HotCat

2011-08-05T17:54:28Z

removed Category:Retroviruses; added Category:Endogenous retroviruses using HotCat

← Previous revision		Revision as of 17:54, 5 August 2011
Line 9:		Line 9:

	[[Category:Genomics]]		[[Category:Genomics]]
	[[Category:~~Retroviruses~~]]		[[Category:Endogenous retroviruses]]

Lorem Ip at 23:10, 5 October 2010

2010-10-05T23:10:18Z

← Previous revision		Revision as of 23:10, 5 October 2010
Line 1:		Line 1:
	{{Orphan\|date=February 2009}}		{{Orphan\|date=February 2009}}
	The [[gene]] known as '''HCP5''' ('''[[Human leukocyte antigen\|HLA]] Complex P5''') is a human [[endogenous retrovirus]], meaning that it is a [[viral fossil\|fossil of an ancient virus]] that at one time infected people, but has now become an integral part of the [[human genome]].		The [[gene]] known as '''HCP5''' ('''[[Human leukocyte antigen\|HLA]] Complex P5''') is a human [[endogenous retrovirus]], meaning that it is a [[viral fossil\|fossil of an ancient virus]] that at one time infected people, but has now become an integral part of the [[human genome]].<ref name=SN>AIDS Abated, B. Vastag, Science News Vol.172 No.3, 21 July 2007</ref>


	One variation of '''HCP5''' appears to provide some delay or resistance to the development of [[AIDS]] when a person is infected with [[HIV]]. This variation of '''HCP5''' frequently occurs in conjunction with a particular version of an [[immune system]] gene called [[HLA-B]]<ref~~>AIDS~~ ~~Abated, B. Vastag, Science News Vol.172 No.3, 21 July 2007<~~/~~ref~~>.		One variation of '''HCP5''' appears to provide some delay or resistance to the development of [[AIDS]] when a person is infected with [[HIV]]. This variation of '''HCP5''' frequently occurs in conjunction with a particular version of an [[immune system]] gene called [[HLA-B]].<ref name=SN/>

	==Notes==		==Notes==